Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dunn

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Internet Interventions|October 14, 2021
Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic painErin M Anderson Goodell, Courtney Nordeck, Patrick H Finan, et al.
Journal of Addiction Medicine|October 7, 2021
Integration of Patient-reported Outcomes Assessment Into Routine Care for Patients Receiving Residential Treatment for Alcohol and/or Substance Use DisorderCameron M Yi, Andrew S Huhn, J Gregory Hobelmann, et al.
Journal of Addiction Medicine|November 26, 2024
Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-experimental ComparisonAnjalee Sharma, Kelly E Dunn, Katja Schmid-Doyle, et al.
JAMA Network Open|October 14, 2025
Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical TrialRajinder Shiwach, Bernard Le Foll, Hannu Alho, et al.
Frontiers in Psychiatry|March 26, 2024
Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical populationCecilia L Bergeria, Brandon Park, Prem Umang Satyavolu, et al.
JAMA Network Open|December 17, 2025
Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical TrialRajinder Shiwach, Bernard Le Foll, Hannu Alho, et al.
Journal of Substance Use and Addiction Treatment|March 7, 2023
Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational studyJennifer D Ellis, Jill A Rabinowitz, Orrin D Ware, et al.
Drug and Alcohol Dependence|November 1, 2019
Increased neural activity in the right dorsolateral prefrontal cortex during a risky decision-making task is associated with cocaine use in methadone-maintained patientsAndrew S Huhn, Robert K Brooner, Mary M Sweeney, et al.
Experimental and Clinical Psychopharmacology|June 7, 2021
Wireless electroencephalography (EEG) to monitor sleep among patients being withdrawn from opioids: Evidence of feasibility and utilityKelly E Dunn, Patrick H Finan, Andrew S Huhn, et al.
JAMA Network Open|February 28, 2024
Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use TreatmentMartin Hochheimer, Justin C Strickland, Jill A Rabinowitz, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Internet Interventions|October 14, 2021
Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic painErin M Anderson Goodell, Courtney Nordeck, Patrick H Finan, et al.
Journal of Addiction Medicine|October 7, 2021
Integration of Patient-reported Outcomes Assessment Into Routine Care for Patients Receiving Residential Treatment for Alcohol and/or Substance Use DisorderCameron M Yi, Andrew S Huhn, J Gregory Hobelmann, et al.
Journal of Addiction Medicine|November 26, 2024
Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-experimental ComparisonAnjalee Sharma, Kelly E Dunn, Katja Schmid-Doyle, et al.
JAMA Network Open|October 14, 2025
Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical TrialRajinder Shiwach, Bernard Le Foll, Hannu Alho, et al.
Frontiers in Psychiatry|March 26, 2024
Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical populationCecilia L Bergeria, Brandon Park, Prem Umang Satyavolu, et al.
JAMA Network Open|December 17, 2025
Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical TrialRajinder Shiwach, Bernard Le Foll, Hannu Alho, et al.
Journal of Substance Use and Addiction Treatment|March 7, 2023
Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational studyJennifer D Ellis, Jill A Rabinowitz, Orrin D Ware, et al.
Drug and Alcohol Dependence|November 1, 2019
Increased neural activity in the right dorsolateral prefrontal cortex during a risky decision-making task is associated with cocaine use in methadone-maintained patientsAndrew S Huhn, Robert K Brooner, Mary M Sweeney, et al.
Experimental and Clinical Psychopharmacology|June 7, 2021
Wireless electroencephalography (EEG) to monitor sleep among patients being withdrawn from opioids: Evidence of feasibility and utilityKelly E Dunn, Patrick H Finan, Andrew S Huhn, et al.
JAMA Network Open|February 28, 2024
Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use TreatmentMartin Hochheimer, Justin C Strickland, Jill A Rabinowitz, et al.
Pageof 17